Published in Medical Letter on the CDC and FDA, February 1st, 2009
The key hires are David King, Ph.D., vice president, research, formerly of Medarex; Hamza Suria, vice president, corporate development, joining from Maxygen; and Steve Neben, Ph.D., senior director, project and alliance management, previously with XOMA.
“Following our successful $34 million Series B financing at the end of 2007, we set plans in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.